Skip to Content

Join the 'Gamunex' group to help and get support from people like you.

Gamunex News

'Immunotherapy' in Monkeys Shows Promise as Long-Term HIV Treatment

Posted 13 Mar 2017 by Drugs.com

MONDAY, March 13, 2017 – Lab experiments with monkeys suggest that "immunotherapy" holds promise as a long-term treatment for HIV, researchers say. Treatment with two anti-HIV antibodies right after infection might help keep the AIDS-causing virus in check for a prolonged period, according to the new study. Despite an arsenal of HIV drugs, effective long-term treatment remains elusive because inactive versions of the virus lie in wait for an opportunity to attack the immune system, said the researchers from Rockefeller University in New York City and the U.S. National Institutes of Health. "This [new] form of therapy can induce potent immunity to HIV, allowing the host to control the infection," said Michel Nussenzweig, head of Rockefeller's laboratory of molecular immunology. "It works by taking advantage of the immune system's natural defenses, similar to what happens in some forms ... Read more

Related support groups: HIV Infection, Pre-Exposure Prophylaxis, Hizentra, RhoGAM, Gammagard, Gamunex, Privigen, Diagnosis and Investigation, Carimune, Immune Globulin Intravenous, Gamunex-C, Hepatitis B Immune Globulin, Vivaglobin, Hyqvia, Synagis, Rabies Immune Globulin, Human, Tetanus Immune Globulin, Rhophylac, Rho (D) Immune Globulin, Cuvitru

Health Tip: Could Allergy Shots Help You?

Posted 21 Feb 2017 by Drugs.com

-- If you have allergies, regular shots (immunotherapy) are designed to make you less sensitive to allergens over time. The American Academy of Allergy, Asthma and Immunology says you may be a candidate for allergy shots if: Your symptoms are moderate-to-severe and your allergy season lasts a few months or more. You want to avoid long-term use of allergy medications. You can commit the time needed for getting regular allergy shots. You can afford the cost of allergy shots and related medical visits. Read more

Related support groups: Allergic Reactions, Allergies, Benadryl, Hydroxyzine, Zyrtec, Promethazine, Claritin, Loratadine, Diphenhydramine, Allegra, Allergic Rhinitis, Phenergan, Hay Fever, Vistaril, Cetirizine, Cyproheptadine, Atarax, Fexofenadine, Periactin, Xyzal

Densensitization Procedure Helps Hard-to-Match Kidney Recipients

Posted 27 Jul 2011 by Drugs.com

WEDNESDAY, July 27 – A combination therapy that "desensitizes" kidney transplant recipients could help hard-to-match patients find a needed kidney faster. The desensitization procedure combines the use of plasmapheresis – a machine that filters the blood plasma to remove antibodies – and low-doses of a medication called intravenous immune globulin (IVIG). The combination of these therapies improves survival rates dramatically. Eight years after receiving a transplant, survival rates were 81 percent for those who received the treatment compared to just 31 percent for people who had to stay on dialysis, new research found. "This is a huge unmet problem. There are probably as many as 30,000 people who have been exposed to foreign tissue waiting for a kidney. They're really hard to match," explained study author Dr. Robert Montgomery, director of the comprehensive transplant program at ... Read more

Related support groups: Renal Transplant, Gammagard, Gamunex, Privigen, Carimune, Immune Globulin Intravenous, Sandoglobulin, Octagam, Gammar-P IV, Carimune NF, Venoglobulin-S 10%, Iveegam En, Gamimune, Panglobulin, Gammaplex, Gamimune N 5%, Polygam S/D, Gammagard S/D, Flebogamma, Venoglobulin-S 5%

Talecris Biotherapeutics Receives FDA Approval for Gamunex-C

Posted 17 Oct 2010 by Drugs.com

RESEARCH TRIANGLE PARK , N.C., Oct. 14 /PRNewswire-FirstCall/ – Talecris Biotherapeutics (Nasdaq: TLCR) announced today that the U.S. Food and Drug Administration (FDA) approved Gamunex-C (Immune Globulin Injection [Human], 10% Caprylate/Chromatography Purified) for subcutaneous administration in the treatment of primary immunodeficiency (PI). The newly approved Gamunex-C provides both the intravenous route of administration and a new subcutaneous route of administration. The intravenous delivery mode is approved to treat PI, chronic inflammatory demyelinating polyneuropathy (CIDP), and idiopathic thrombocytopenic purpura (ITP). The subcutaneous mode is approved to treat only PI. The difference between Gamunex and Gamunex-C is the labeling and packaging information. Gamunex-C labeling describes both the intravenous and subcutaneous routes of administration, whereas Gamunex labeling ... Read more

Related support groups: Primary Immunodeficiency Syndrome, Gamunex, Immune Globulin Subcutaneous

Ask a Question

Further Information

Related Condition Support Groups

Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Primary Immunodeficiency Syndrome, Evan's Syndrome, Idiopathic (Immune) Thrombocytopenic Purpura

Gamunex Patient Information at Drugs.com